- Home
- WSBF vs LRMR Comparison
WSBF vs LRMR Comparison
Compare WSBF & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | LRMR |
|---|---|---|
| Founded | 1921 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.7M | 280.0M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSBF | LRMR |
|---|---|---|
| Price | $17.24 | $5.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.29 |
| AVG Volume (30 Days) | 35.9K | ★ 6.6M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 46.53 | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.61 | $1.61 |
| 52 Week High | $18.88 | $6.42 |
Technical Indicators
Market Signals| Indicator | WSBF | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 67.55 |
| Support Level | $17.22 | $3.18 |
| Resistance Level | $18.63 | $6.42 |
| Average True Range (ATR) | 0.53 | 0.53 |
| MACD | -0.11 | 0.14 |
| Stochastic Oscillator | 27.81 | 75.57 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.